Top Industry Leaders in the Cholesterol Management Devices Market
Latest Cholesterol Management Devices Companies Update
-
Jan 2023: Leading global health technology provider Royal Philips has revealed two new developments in MR-only workflows to improve head and neck cancer radiation modeling and imaging. With FDA 510(k) clearance, the company's artificial intelligence (AI) enabled MRCAT Head and Neck radiotherapy application is now commercially available in the United States. It permits the use of MR as the sole or primary imaging modality for radiotherapy planning for the handling of soft tissue tumors in the head and neck, as well as the brain, pelvis, and prostate. According to an announcement by Philips, the most recent DSPS ProminentTM positioning system from MacroMedics is compatible with the Philips MR Head Neck Coil because of a development relationship with the patient-positioning business. This innovative solution combines the comfort-enhancing, positional precision, and stability qualities of MacroMedics' mask with the excellent soft tissue imaging capabilities and high-resolution picture quality of Philips' head and neck coil.
List of Cholesterol Management Devices Key companies in the market
- Boston Scientific Corporation (US)
- Medtronic (US)
- St. Jude Medical, LLC. (Canada)
- Koninklijke Philips N.V. (US)
- Roche Diagnostics (US)
- Abbott (US)
- Alere (US)
- Sorin Group (Italy)
- BIOTRONIK SE & Co. KG (Germany)
- Bio-AMD (UK)